Viewing Study NCT00165802


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-02-01 @ 9:40 PM
Study NCT ID: NCT00165802
Status: COMPLETED
Last Update Posted: 2013-05-22
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors
Sponsor: Eisai Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: E7974-A001-103
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Eisai Medical Services
Old Organization: Eisai Medical Research Inc.

Collaborators